The Future of GLP-1 Drugs: Overcoming Roadblocks for Patients and Pharma The GLP-1 arena has become a battleground between pharmaceutical…
Browsing: GLP1
GLP-1 drugs have long been hailed for their effectiveness in treating diabetes and obesity. However, a recent study presented at…
Advocates for expanded coverage of GLP-1 medications for obesity are hopeful that the issue will be revisited in the future.…
The use of GLP-1 drugs in people with diabetes has been associated with a low but elevated risk of developing…
Credit: Unsplash/CC0 Public Domain As Australia faces a turning point in obesity management, researchers from Monash University have contributed new…
Anecdotal reports and a case series suggest that Ozempic and other GLP-1 receptor agonists may in … More some cases…
Glucagon-like peptide (GLP-1) receptor agonists like semaglutide and liraglutide are already … More game-changers for obesity and type 2 diabetes.…
The popularity of GLP-1 receptor agonists have prompted some trainers to offer regimens that … More specifically deal with the…
A groundbreaking study led by two undergraduate medicine students at the University of Galway has shed light on the impact…
Sustainable prescribing of GLP-1s coming to Employer Health Plans As the demand for GLP-1 medications like Mounjaro and Ozempic continues…
